# Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents

> **NCT01245374** · PHASE4 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 103 (actual)

## Conditions studied

- Growth Hormone Disorder
- Growth Hormone Deficiency in Children
- Foetal Growth Problem
- Small for Gestational Age
- Genetic Disorder
- Turner Syndrome
- Chronic Kidney Disease
- Chronic Renal Insufficiency
- Delivery Systems

## Interventions

- **DEVICE:** Norditropin NordiFlex®

## Key facts

- **NCT ID:** NCT01245374
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2017-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01245374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01245374, "Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01245374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*